The Heart Protection Study: High-risk patients benefit from statins, regardless of LDL-C level

Article Type

Article

Changed

Fri, 11/16/2018 - 08:07

Display Headline

The Heart Protection Study: High-risk patients benefit from statins, regardless of LDL-C level

Author(s)

Hitinder S. Gurm, MBBS

Byron Hoogwerf, MD

Article PDF

content_70_991.pdf

Author and Disclosure Information

Hitinder S. Gurm, MBBS
Department of Cardiovascular Medicine, The Cleveland Clinic

Byron Hoogwerf, MD
Department of Endocrinology and Metabolism; Section of Preventive Cardiology, Department of Cardiovascular Medicine, Director; Internal Medicine Residency Program, The Cleveland Clinic

Address: Hitinder S. Gurm, MBBS, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Hoogwerf has indicated that he is a consultant for Astra Zeneca and Merck, and is on the speakers’ bureau for Merck and Schering Plough.

Issue

Cleveland Clinic Journal of Medicine - 70(11)

Publications

Cleveland Clinic Journal of Medicine

Topics

Drug Therapy

Preventive Care

Vascular

Page Number

991-997

Sections

Reviews

Author(s)

Hitinder S. Gurm, MBBS

Byron Hoogwerf, MD

Author(s)

Hitinder S. Gurm, MBBS

Byron Hoogwerf, MD

Author and Disclosure Information

Hitinder S. Gurm, MBBS
Department of Cardiovascular Medicine, The Cleveland Clinic

Byron Hoogwerf, MD
Department of Endocrinology and Metabolism; Section of Preventive Cardiology, Department of Cardiovascular Medicine, Director; Internal Medicine Residency Program, The Cleveland Clinic

Address: Hitinder S. Gurm, MBBS, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Hoogwerf has indicated that he is a consultant for Astra Zeneca and Merck, and is on the speakers’ bureau for Merck and Schering Plough.

Author and Disclosure Information

Hitinder S. Gurm, MBBS
Department of Cardiovascular Medicine, The Cleveland Clinic

Byron Hoogwerf, MD
Department of Endocrinology and Metabolism; Section of Preventive Cardiology, Department of Cardiovascular Medicine, Director; Internal Medicine Residency Program, The Cleveland Clinic

Address: Hitinder S. Gurm, MBBS, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Hoogwerf has indicated that he is a consultant for Astra Zeneca and Merck, and is on the speakers’ bureau for Merck and Schering Plough.

Article PDF

content_70_991.pdf

Article PDF

content_70_991.pdf

Issue

Cleveland Clinic Journal of Medicine - 70(11)

Issue

Cleveland Clinic Journal of Medicine - 70(11)

Page Number

991-997